PubMed:16410744 / 1261-1455 JSONTXT

{"project":"LitCoin-sentences","denotations":[{"id":"T10","span":{"begin":0,"end":194},"obj":"Sentence"}],"text":"SSCP followed by DNA sequencing of the kinase domain (exons 18-21) of the EGFR gene revealed mutations in 2 ou of 69 (3%) glioblastomas in Japan and in 4 of 81 (5%) glioblastomas in Switzerland."}

{"project":"LitCoin-entities","denotations":[{"id":"2726","span":{"begin":74,"end":78},"obj":"GeneOrGeneProduct"},{"id":"2727","span":{"begin":122,"end":135},"obj":"DiseaseOrPhenotypicFeature"},{"id":"2728","span":{"begin":165,"end":178},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A22","pred":"db_id","subj":"2726","obj":"NCBIGene:1956"},{"id":"A23","pred":"db_id","subj":"2727","obj":"MESH:D005909"},{"id":"A24","pred":"db_id","subj":"2728","obj":"MESH:D005909"}],"namespaces":[{"prefix":"_base","uri":"https://w3id.org/biolink/vocab/"},{"prefix":"MESH","uri":"http://id.nlm.nih.gov/mesh/"},{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id="},{"prefix":"NCBIGene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"OMIM","uri":"https://www.omim.org/entry/"},{"prefix":"DBSNP","uri":"https://www.ncbi.nlm.nih.gov/snp/"}],"text":"SSCP followed by DNA sequencing of the kinase domain (exons 18-21) of the EGFR gene revealed mutations in 2 ou of 69 (3%) glioblastomas in Japan and in 4 of 81 (5%) glioblastomas in Switzerland."}

{"project":"LitCoin_Mondo","denotations":[{"id":"T10","span":{"begin":122,"end":135},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T11","span":{"begin":165,"end":178},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A10","pred":"mondo_id","subj":"T10","obj":"0018177"},{"id":"A11","pred":"mondo_id","subj":"T11","obj":"0018177"}],"text":"SSCP followed by DNA sequencing of the kinase domain (exons 18-21) of the EGFR gene revealed mutations in 2 ou of 69 (3%) glioblastomas in Japan and in 4 of 81 (5%) glioblastomas in Switzerland."}

{"project":"LitCoin-GeneOrGeneProduct-v2","denotations":[{"id":"T9","span":{"begin":39,"end":45},"obj":"GeneOrGeneProduct"},{"id":"T10","span":{"begin":74,"end":78},"obj":"GeneOrGeneProduct"}],"text":"SSCP followed by DNA sequencing of the kinase domain (exons 18-21) of the EGFR gene revealed mutations in 2 ou of 69 (3%) glioblastomas in Japan and in 4 of 81 (5%) glioblastomas in Switzerland."}

{"project":"LitCoin-GeneOrGeneProduct-v0","denotations":[{"id":"T25","span":{"begin":39,"end":45},"obj":"GeneOrGeneProduct"},{"id":"T26","span":{"begin":74,"end":78},"obj":"GeneOrGeneProduct"},{"id":"T27","span":{"begin":93,"end":107},"obj":"GeneOrGeneProduct"},{"id":"T28","span":{"begin":145,"end":153},"obj":"GeneOrGeneProduct"}],"text":"SSCP followed by DNA sequencing of the kinase domain (exons 18-21) of the EGFR gene revealed mutations in 2 ou of 69 (3%) glioblastomas in Japan and in 4 of 81 (5%) glioblastomas in Switzerland."}

{"project":"LitCoin-Disease-MeSH","denotations":[{"id":"T11","span":{"begin":122,"end":135},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T12","span":{"begin":165,"end":178},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A11","pred":"originalLabel","subj":"T11","obj":"D005909"},{"id":"A12","pred":"originalLabel","subj":"T12","obj":"D005909"}],"text":"SSCP followed by DNA sequencing of the kinase domain (exons 18-21) of the EGFR gene revealed mutations in 2 ou of 69 (3%) glioblastomas in Japan and in 4 of 81 (5%) glioblastomas in Switzerland."}

{"project":"LitCoin-GeneOrGeneProduct-v3","denotations":[{"id":"T6","span":{"begin":74,"end":78},"obj":"GeneOrGeneProduct"}],"text":"SSCP followed by DNA sequencing of the kinase domain (exons 18-21) of the EGFR gene revealed mutations in 2 ou of 69 (3%) glioblastomas in Japan and in 4 of 81 (5%) glioblastomas in Switzerland."}

{"project":"LitCoin-MeSH-Disease-2","denotations":[{"id":"T12","span":{"begin":122,"end":135},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T13","span":{"begin":165,"end":178},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A12","pred":"ID:","subj":"T12","obj":"D005909"},{"id":"A13","pred":"ID:","subj":"T13","obj":"D005909"}],"text":"SSCP followed by DNA sequencing of the kinase domain (exons 18-21) of the EGFR gene revealed mutations in 2 ou of 69 (3%) glioblastomas in Japan and in 4 of 81 (5%) glioblastomas in Switzerland."}

{"project":"LitCoin-MONDO_bioort2019","denotations":[{"id":"T11","span":{"begin":122,"end":135},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T12","span":{"begin":165,"end":178},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A11","pred":"#label","subj":"T11","obj":"D005909"},{"id":"A12","pred":"#label","subj":"T12","obj":"D005909"}],"text":"SSCP followed by DNA sequencing of the kinase domain (exons 18-21) of the EGFR gene revealed mutations in 2 ou of 69 (3%) glioblastomas in Japan and in 4 of 81 (5%) glioblastomas in Switzerland."}

{"project":"LitCoin-training-merged","denotations":[{"id":"T6","span":{"begin":74,"end":78},"obj":"GeneOrGeneProduct"},{"id":"T12","span":{"begin":165,"end":178},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T11","span":{"begin":122,"end":135},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A12","pred":"#label","subj":"T12","obj":"D005909"},{"id":"A11","pred":"#label","subj":"T11","obj":"D005909"}],"text":"SSCP followed by DNA sequencing of the kinase domain (exons 18-21) of the EGFR gene revealed mutations in 2 ou of 69 (3%) glioblastomas in Japan and in 4 of 81 (5%) glioblastomas in Switzerland."}

{"project":"PubmedHPO","denotations":[{"id":"T10","span":{"begin":122,"end":135},"obj":"HP_0100843"},{"id":"T11","span":{"begin":165,"end":178},"obj":"HP_0100843"}],"text":"SSCP followed by DNA sequencing of the kinase domain (exons 18-21) of the EGFR gene revealed mutations in 2 ou of 69 (3%) glioblastomas in Japan and in 4 of 81 (5%) glioblastomas in Switzerland."}

{"project":"DisGeNET","denotations":[{"id":"T4","span":{"begin":74,"end":78},"obj":"gene:1956"},{"id":"T5","span":{"begin":122,"end":135},"obj":"disease:C0017636"},{"id":"T6","span":{"begin":74,"end":78},"obj":"gene:1956"},{"id":"T7","span":{"begin":165,"end":178},"obj":"disease:C0017636"}],"relations":[{"id":"R3","pred":"associated_with","subj":"T4","obj":"T5"},{"id":"R4","pred":"associated_with","subj":"T6","obj":"T7"}],"namespaces":[{"prefix":"gene","uri":"http://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"disease","uri":"http://purl.bioontology.org/ontology/MEDLINEPLUS/"}],"text":"SSCP followed by DNA sequencing of the kinase domain (exons 18-21) of the EGFR gene revealed mutations in 2 ou of 69 (3%) glioblastomas in Japan and in 4 of 81 (5%) glioblastomas in Switzerland."}